Viewing StudyNCT00110188



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00110188
Status: COMPLETED
Last Update Posted: 2015-11-20
First Post: 2005-05-04

Brief Title: Ridaforolimus AP23573MK-8669 in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer AIPCMK-8669-017
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-05
Start Date Type: None
Primary Completion Date: 2007-04
Primary Completion Date Type: ACTUAL
Completion Date: 2007-08
Completion Date Type: ACTUAL
First Submit Date: 2005-05-04
First Submit QC Date: May 4 2005
Study First Post Date: 2005-05-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-11-18
Last Update Post Date: 2015-11-20
Last Update Post Date Type: ESTIMATED